Immunicum AB: Immunicum Announces Corporate Rebranding and Name Change to Mendus AB
Rebranding reflects advancing pipeline in next generation cancer immunotherapies, upcoming manufacturing expansion, and long-term corporate aspirationsThe Company's stock to continue trading under ticker
Source: finanznachrichten.de